Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects Who Have Had an Inadequate Response to Methotrexate [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ASP015K for safety and efficacy in moderate-to-severe rheumatoid arthritis patients with inadequate response to methotrexate; study com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ASP015K

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Arthritis, Rheumatoid | Phase 2 | Status: COMPLETED